Fortitude Family Office’s Rapport Therapeutics RAPP Stock Holding History

Fortitude Family Office’s Portfolio RAPP Stock Details RAPP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.01K	Buy	+30	New	+$1.29K	﹤0.01%	2243

Other funds holding RAPP

CPW

Catalyst Private Wealth San Mateo, California $239M AUM 21.76% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Fortitude Family Office's RAPP Position: Q3 2026 in Review

Fortitude Family Office opened a new position in Rapport Therapeutics (RAPP) in Q3 2026: 30 shares worth $1.01K. The stake represents ﹤0.01% of the portfolio and ranks #2243 among its holdings.

8 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.

Fortitude Family Office held 30 shares of Rapport Therapeutics worth $1.01K as of Q3 2026.
Rapport Therapeutics was a new Fortitude Family Office position in Q3 2026.
Rapport Therapeutics made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2243 holding.
8 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.